Thromboembolic events were more frequent in the direct oral anticoagulants (DOAC) group compared to warfarin in kidney transplant recipients.
Do direct oral anticoagulants improve safety and efficacy outcomes compared to warfarin in kidney transplant recipients?
In kidney transplant recipients, DOACs showed comparable bleeding and mortality to warfarin but were associated with a higher frequency of thromboembolic events.
Absolute Event Rate: 0% vs 0%
Major bleeding and mortality rates were comparable; however, thromboembolic events were more frequent in the DOAC group. Further research on DOAC subtypes, drug interactions, and dosing is warranted.
Park et al. (Fri,) reported a other. Thromboembolic events were more frequent in the direct oral anticoagulants (DOAC) group compared to warfarin in kidney transplant recipients.